Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Five rules for patient-centric leaders

This article was originally published in Scrip

Executive Summary

Patient-centricity is a phrase that keeps popping up in our day-to-day industry exchanges, but no one company has fully determined how to address the inclusion of patient voices in the various levels of business. Paul Simms, chair of pharma-focused events and reports producer eyeforpharma, discusses here how reputation still plays a large part in the measuring of a company's patient-centric efforts and what his five golden rules are for leaders or wannabe frontrunners of the "patient-centricity movement."

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC029163

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel